Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06673121

Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule

Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule (RESEARCH-PN)

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Third Affiliated Hospital of Henan University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study is a prospective multicenter cohort study that primarily evaluates the impact of traditional Chinese medicine treatment on pulmonary nodules

Detailed description

This study is a multicenter, prospective cohort study that will recruit at least 2244 individuals with chest HRCT findings of pulmonary nodules and recommended follow-up by MDT from four research centers. According to whether patients with pulmonary nodules are treated with traditional Chinese medicine, they are divided into a traditional Chinese medicine cohort and a non-traditional Chinese medicine cohort , and are followed up for at least 2 years. The main outcome measures were pulmonary nodule growth (enlargement or new onset) and nodule regression (reduction or disappearance). To evaluate the efficacy of traditional Chinese medicine treatment for patients with pulmonary nodules, secondary outcome measures include nodule volume, average nodule density, doubling time of volume, internal and external signs of nodules, anxiety self-assessment scale, depression self-assessment scale and SF-36 scale.

Conditions

Interventions

TypeNameDescription
DRUGTraditional Chinese MedicineReceived treatment with traditional Chinese medicine

Timeline

Start date
2024-01-03
Primary completion
2028-12-30
Completion
2029-12-30
First posted
2024-11-04
Last updated
2024-11-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06673121. Inclusion in this directory is not an endorsement.